BANX vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BANX exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational performance, but lacks an Altman Z-Score for distress risk assessment. The stock appears undervalued based on a P/E of 7.74 versus the sector average of 21.04 and trades below its Graham Number of $36.74, though earnings growth has been inconsistent recently. High profitability metrics like 75.8% operating margin and 69.8% net margin contrast with declining revenue growth of -9.8% YoY, raising sustainability concerns. The 9.21% dividend yield is attractive but comes with weak insider sentiment and bearish technicals, warranting caution despite value appeal.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BANX vs JPM: Head-to-Head Comparison
This page compares ArrowMark Financial Corp. (BANX) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.